dupilumab

Documents about dupilumab

• Dupilumab for recalcitrant prurigo nodularis: Case report#335990RCAAP
• Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants#862832ClinicalTrials.gov
• Successful Treatment of Severe Adult Linear IgA Dermatosis Using Dupilumab#68405HAL (France)
• The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction#854123ClinicalTrials.gov
• Dupilumab’s impact on blood parameters in nasal polyposis: 18-month follow-up in real life#644265IRIS
• Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema#836557ClinicalTrials.gov
• Drug-induced sarcoidosis-like reaction following IL-4/IL-13 receptor blockade by dupilumab#194804OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Effect of Dupilumab on Aspirin Intolerance#846123ClinicalTrials.gov
• Dupilumab Compassionate Use Study#895193ClinicalTrials.gov
• Dupilumab-Related Hypereosinophilia in Patients Treated for Type 2 Diseases: Evidence from a 24-Month Prospective Real-Life Study#456865IRIS
• Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)#825602ClinicalTrials.gov
• Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.#982264ClinicalTrials.gov
• Dupilumab De-escalation in Pediatric Atopic Dermatitis#835866ClinicalTrials.gov
• SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"#891753ClinicalTrials.gov
• Dupilumab in Chronic Rhinosinusitis Without Nasal Polyps: Randomized Phase 2 Trial (ORION)#626206ODU Digital Commons
• Molecular Signatures of Cutaneous Dupilumab Response#806292ClinicalTrials.gov
• Real Life Experience Survey of Dupilumab in the Netherlands#813451ClinicalTrials.gov
• Dupilumab for Aspirin-exacerbated Respiratory Disease#884009ClinicalTrials.gov
• Study of REGN3500 and Dupilumab in Patients With Asthma#1009039ClinicalTrials.gov
• Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)#871631ClinicalTrials.gov
• Early-onset Dupilumab Effects in CRSwNP#894191ClinicalTrials.gov
• Dupilumab in Eosinophilic Gastritis#905183ClinicalTrials.gov
• Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis#807778ClinicalTrials.gov
• Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)#825225ClinicalTrials.gov
• Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases#290987ClinicalTrials.gov
• Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China#803912ClinicalTrials.gov
• Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis#832448ClinicalTrials.gov
• Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis#866564ClinicalTrials.gov
• Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma#881833ClinicalTrials.gov
• Dupilumab in the Treatment of Pediatric Alopecia Areata#897737ClinicalTrials.gov
• Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)#907133ClinicalTrials.gov
• Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis#876604ClinicalTrials.gov
• Ultrastructural Mucosal Response to Dupilumab in Chronic Rhinosinusitis With Nasal Polyps: A Pilot Study.#143261NCBI PubMed Central
• Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety#478485Europe PMC
• Therapeutic Modulation of Dupilumab in Patients with Severe Atopic Dermatitis: Clinical Effectiveness in Real Life#625563IRIS
• Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)#902476ClinicalTrials.gov
• Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis#1008471ClinicalTrials.gov
• Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids#840324ClinicalTrials.gov
• Replication of the Heads Up Atopic Dermatitis Trial With Registry Data#843507ClinicalTrials.gov
• The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis#860214ClinicalTrials.gov
• Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis#894798ClinicalTrials.gov
• Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)#905974ClinicalTrials.gov
• AIM4 Next Step: Comparing ICS dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation#142674HAL (France)
• Real-World Identification of Eosinophilic COPD Patients Potentially Eligible for Dupilumab: A Retrospective Observational Study.#465368NCBI PubMed Central
• Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation#851792ClinicalTrials.gov
• Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry.#436929NCBI PubMed Central
• The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment#854633ClinicalTrials.gov
• Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)#993610ClinicalTrials.gov
• Improvement of Mixed Inflammatory Environment in Nasal Secretions of Diffuse Type 2 Chronic Rhinosinusitis With Nasal Polyps Under Dupilumab.#265389NCBI PubMed Central
• Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer#387169ClinicalTrials.gov